TVWM
UTHR icon

Tower View Wealth Management’s United Therapeutics UTHR Stock Holding History

Tower View Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Buy
3,006
+273
+10% +$154K 0.72% 40
2026
Q1 		$1.62M Buy
2,733
+2,658
+3,544% +$1.32M 0.83% 36
2025
Q4 		$36.5K Hold
75
– – 0.02% 95
2025
Q3 		$31.4K Hold
75
– – 0.02% 94
2025
Q2 		$21.6K Hold
75
– – 0.01% 116
2025
Q1 		$23.1K Hold
75
– – 0.01% 98
2024
Q4 		$26.5K Sell
75
-25
-25% -$9.19K 0.01% 97
2024
Q3 		$35.8K Hold
100
– – 0.02% 91
2024
Q2 		$31.9K Hold
100
– – 0.02% 90
2024
Q1 		$23K Hold
100
– – 0.01% 104
2023
Q4 		$22K Hold
100
– – 0.01% 101
2023
Q3 		$23K Hold
100
– – 0.02% 95
2023
Q2 		$22K Hold
100
– – 0.01% 97
2023
Q1 		$22K Hold
100
– – 0.01% 96
2022
Q4 		$28K Hold
100
– – 0.02% 91
2022
Q3 		$21K Hold
100
– – 0.02% 97
2022
Q2 		$24K Hold
100
– – 0.02% 95
2022
Q1 		$18K Hold
100
– – 0.01% 130
2021
Q4 		$22K Buy
100
+21
+27% +$4.12K 0.01% 129
2021
Q3 		$15K Hold
79
– – 0.01% 152
2021
Q2 		$14K Hold
79
– – 0.01% 116
2021
Q1 		$13K Hold
79
– – 0.01% 124
2020
Q4 		$12K Hold
79
– – 0.01% 123
2020
Q3 		$8K Hold
79
– – 0.01% 121
2020
Q2 		$10K Hold
79
– – 0.01% 101
2020
Q1 		$7K Hold
79
– – 0.01% 99
2019
Q4 		$7K Hold
79
– – 0.01% 120
2019
Q3 		$6K Hold
79
– – 0.01% 119
2019
Q2 		$6K Hold
79
– – 0.01% 116
2019
Q1 		$9K Hold
79
– – 0.01% 115
2018
Q4 		$9K Hold
79
– – 0.01% 113
2018
Q3 		$10K Buy
+79
New +$9.77K 0.01% 130

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Tower View Wealth Management's UTHR Position: Q2 2026 in Review

Tower View Wealth Management increased its United Therapeutics (UTHR) stake by 10% in Q2 2026, buying an estimated $154K and bringing the position to 3,006 shares worth $1.63M. The position accounts for 0.72% of the portfolio, ranked #40.

Tower View Wealth Management first reported a position in UTHR in Q3 2018 and has held it in 32 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Tower View Wealth Management held 3,006 shares of United Therapeutics worth $1.63M as of Q2 2026.
  • Tower View Wealth Management bought 273 United Therapeutics shares in Q2 2026, an estimated $154K.
  • United Therapeutics made up 0.72% of Tower View Wealth Management's portfolio in Q2 2026, its #40 holding.
  • Tower View Wealth Management first reported a position in United Therapeutics in Q3 2018 and has held it in 32 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Tower View Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.